Steven W. Baertschi earned his PhD in organic chemistry at Vanderbilt University in 1989 and joined Eli Lilly and Company as a research scientist that same year. He retired from Lilly in 2015 and now consults for numerous pharmaceutical companies. His research interests include drug stability and purity, drug degradation chemistry and photochemistry, control strategies for impurities, (including mutagenic impurities), and analytical methodologies. He has published more than 60 refereed scientific articles, 30 book chapters, and edited two editions of a book on drug degradation. Steven is an American Chemical Society member since 1980 and is a fellow of the American Association of Pharmaceutical Scientists (2007).
